On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
作者信息
Caffo O, Zagonel V, Baldessari C, Berruti A, Bortolus R, Buti S, Ceresoli G L, Donini M, Ermacora P, Fornarini G, Fratino L, Masini C, Massari F, Mosca A, Mucciarini C, Procopio G, Tucci M, Verri E, Zucali P, Buttigliero C
机构信息
Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
出版信息
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
Abstract
摘要
相似文献
1
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
2
Does androgen deprivation therapy protect against severe complications from COVID-19?
Ann Oncol. 2020 Oct;31(10):1419-1420. doi: 10.1016/j.annonc.2020.06.023. Epub 2020 Jul 9.
3
Androgen deprivation and SARS-CoV-2 in men with prostate cancer.
Ann Oncol. 2020 Oct;31(10):1417-1418. doi: 10.1016/j.annonc.2020.06.015. Epub 2020 Jun 29.
4
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
5
Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?
Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
6
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
7
COVID-19 and The Prostate Cancer Connection.
Can J Urol. 2020 Oct;27(5):10346.
8
[Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].
Urologe A. 2020 Oct;59(10):1251-1253. doi: 10.1007/s00120-020-01305-7.
9
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
10
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14.
引用本文的文献
1
A Comment on Coronavirus Disease 2019 and the Hair.
Int J Trichology. 2024 Jan-Dec;16(1-6):1-5. doi: 10.4103/ijt.ijt_179_20. Epub 2025 Apr 18.
2
Antiandrogens as Therapies for COVID-19: A Systematic Review.
Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298.
3
[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].
Prog Urol. 2022 Dec;32(16):1421-1430. doi: 10.1016/j.purol.2022.09.005. Epub 2022 Sep 13.
4
Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
J Korean Med Sci. 2022 Aug 8;37(31):e237. doi: 10.3346/jkms.2022.37.e237.
5
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
JNCI Cancer Spectr. 2022 May 2;6(3). doi: 10.1093/jncics/pkac035.
6
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.
JAMA Netw Open. 2022 Apr 1;5(4):e227852. doi: 10.1001/jamanetworkopen.2022.7852.
7
The clinical impact of androgen deprivation therapy on SARS-CoV-2 infection rates and disease severity.
Turk J Urol. 2021 Nov;47(6):495-500. doi: 10.5152/tud.2021.21278.
8
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review.
Crit Rev Oncol Hematol. 2021 Nov;167:103491. doi: 10.1016/j.critrevonc.2021.103491. Epub 2021 Oct 6.
9
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
PLoS One. 2021 Oct 7;16(10):e0255966. doi: 10.1371/journal.pone.0255966. eCollection 2021.
10
Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
Prostate. 2021 Dec;81(16):1349-1354. doi: 10.1002/pros.24232. Epub 2021 Sep 13.
本文引用的文献
1
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
Zotero 插件